Cargando…

Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study

Detalles Bibliográficos
Autores principales: Jorgensen, Kristin, Chopra, Adity, Sexton, Joseph, Tveter, Anne T, Hov, Johannes R., Jyssum, Ingrid, Nissen-Meyer, Lise Sofie H., Vaage, John T, Syversen, Silje W, Goll, Guro L, Lund-Johansen, Fridtjof, Jahnsen, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252385/
http://dx.doi.org/10.1016/S0168-8278(22)00986-2
_version_ 1784740252595781632
author Jorgensen, Kristin
Chopra, Adity
Sexton, Joseph
Tveter, Anne T
Hov, Johannes R.
Jyssum, Ingrid
Nissen-Meyer, Lise Sofie H.
Vaage, John T
Syversen, Silje W
Goll, Guro L
Lund-Johansen, Fridtjof
Jahnsen, Jørgen
author_facet Jorgensen, Kristin
Chopra, Adity
Sexton, Joseph
Tveter, Anne T
Hov, Johannes R.
Jyssum, Ingrid
Nissen-Meyer, Lise Sofie H.
Vaage, John T
Syversen, Silje W
Goll, Guro L
Lund-Johansen, Fridtjof
Jahnsen, Jørgen
author_sort Jorgensen, Kristin
collection PubMed
description
format Online
Article
Text
id pubmed-9252385
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92523852022-07-05 Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study Jorgensen, Kristin Chopra, Adity Sexton, Joseph Tveter, Anne T Hov, Johannes R. Jyssum, Ingrid Nissen-Meyer, Lise Sofie H. Vaage, John T Syversen, Silje W Goll, Guro L Lund-Johansen, Fridtjof Jahnsen, Jørgen J Hepatol POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects European Association for the Study of the Liver. Published by Elsevier B.V. 2022-07 2022-07-04 /pmc/articles/PMC9252385/ http://dx.doi.org/10.1016/S0168-8278(22)00986-2 Text en Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects
Jorgensen, Kristin
Chopra, Adity
Sexton, Joseph
Tveter, Anne T
Hov, Johannes R.
Jyssum, Ingrid
Nissen-Meyer, Lise Sofie H.
Vaage, John T
Syversen, Silje W
Goll, Guro L
Lund-Johansen, Fridtjof
Jahnsen, Jørgen
Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
title Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
title_full Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
title_fullStr Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
title_full_unstemmed Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
title_short Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
title_sort immune response and safety in standard and third dose sars-cov-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
topic POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252385/
http://dx.doi.org/10.1016/S0168-8278(22)00986-2
work_keys_str_mv AT jorgensenkristin immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT chopraadity immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT sextonjoseph immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT tveterannet immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT hovjohannesr immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT jyssumingrid immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT nissenmeyerlisesofieh immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT vaagejohnt immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT syversensiljew immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT gollgurol immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT lundjohansenfridtjof immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy
AT jahnsenjørgen immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy